Request Deal Involvement
Cormorant Asset Management led a $150m Series B funding round in Rapport Therapeutics.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Latham & Watkins
pr advisors
Ten Bridge Communications
or
Principals
bidder
SOFINNOVA INVESTMENTS
bidder
T. ROWE PRICE GROUP INC
bidder
SURVEYOR CAPITAL
bidder
FIDELITY MANAGEMENT & RESEARCH COMPANY
bidder
GOLDMAN SACHS ASSET MANAGEMENT
bidder
LOGOS CAPITAL
target
RAPPORT THERAPEUTICS INC
bidder
PERCEPTIVE ADVISORS LLC
bidder
JOHNSON & JOHNSON INNOVATION - JJDC INC
bidder
CORMORANT ASSET MANAGEMENT
bidder
THIRD ROCK VENTURES LLC
bidder
ARCH VENTURE PARTNERS
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite